I detail why it will likely beat the Nasdaq 100 in 2025.

Expand Energy (NASDAQ:EXE) +2.7% in Thursday's trading to an all-time high of $108.83 as J.P. Morgan launches coverage with an Outperform rating and $112 price target, citing large-scale exposure ...

is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

Fintel reports that on January 16, 2025, JP Morgan initiated coverage of Expand Energy (NasdaqGS:EXE) with a Overweight recommendation. Price T Rowe Associates holds 14,203K shares representing 6. ...

today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16, 2025. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the ...

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan ...

Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) was one of the biggest gainers in the consumer sector on Thursday after J.P. Morgan added the stock to its Analyst Focus List on its view the retailer ...

Morgan Stanley analyst Michael Cyprys maintained a Buy rating on Nasdaq (NDAQ – Research Report) today and set a price target of $93.00. The company’s shares closed yesterday at $78.39.

Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare ...

A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of ...